Chronic administration of UK-114, a multifunctional emerging protein, modulates the Th1/Th2 cytokine pattern and experimental autoimmune diseases.

Panerai, A E; Sacerdote, P; Bianchi, M; Nicoletti, F; Manfredi, B; Gaspani, L; Bartorelli, A; Ceciliani, F; Ronchi, S

Panerai, A E; Sacerdote, P; Bianchi, M; Nicoletti, F; Manfredi, B; Gaspani, L; Bartorelli, A; Ceciliani, F; Ronchi, S.

Affiliation

Panerai AE; Department of Pharmacology, University of Milano, Italy. panerai@imiucca.csi.unimi.it

Ann N Y Acad Sci ; 876: 229-35, 1999 Jun 22.

Article in En | MEDLINE | ID: mdl-10415614

Subject(s)

Autoimmune Diseases/metabolism; Cytokines/metabolism; Neoplasm Proteins/administration & dosage; Th1 Cells/metabolism; Th2 Cells/metabolism; Animals; Concanavalin A/pharmacology; Diabetes Mellitus, Type 1/prevention & control; Female; Interferon-gamma/antagonists & inhibitors; Interferon-gamma/metabolism; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Neoplasm Proteins/pharmacology; Rats; Rats, Inbred Lew; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Cytokines / Th2 Cells / Th1 Cells / Neoplasm Proteins Limits: Animals Language: En Journal: Ann N Y Acad Sci Year: 1999 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links